Arrivo BioVentures LLC

About:

Arrivo BioVentures is a pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care.

Website: http://arrivobio.com/

Top Investors: Jazz Pharmaceuticals, Orlando Health Ventures, Solas BioVentures, Rex Health Ventures

Description:

Our expertise is drug development. Whether we are developing a reformulated product, a new chemical entity, or a biologic, the team at Arrivo BioVentures has expertise in identifying regulatory strategies to expedite the path to approval and the efficient implementation of the clinical programs themselves. We coordinate with the FDA (and other regulatory bodies) early and often to gain agreement on the development programs for our products, minimizing surprises and speeding implementation.

Total Funding Amount:

$94.3M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Morrisville, North Carolina, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)arrivobio.com

Founders:

Michael F. Ackermann, Stephen Butts

Number of Employees:

11-50

Last Funding Date:

2023-11-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai